Clinical trial
Phase 1 + 2a Proof of Concept Study of Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)
NCT01793415 is registered in ClinicalTrials.gov with PharmaLundensis AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 + 2a Proof of Concept Study of Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)
- Lead sponsor
- PharmaLundensis AB
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- February 28, 2013
- Completion date
- December 31, 2013
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic fatigue syndrome